Рет қаралды 176
Moderated by Gairdner Early Career Investigators, this session provides a platform for presenting cutting-edge research in mRNA therapeutics.
Featuring Yizhou Dong from the Icahn School of Medicine at Mount Sinai, Christian J. Kastrup from the Versiti Blood Research Institute, and Sarah Hedtrich from Charité - Universitätsmedizin Berlin, the discussion delves into the latest advancements and applications of mRNA technology.